Robeco Institutional Asset Management B.V. Has $256.50 Million Stock Position in Colgate-Palmolive (NYSE:CL)

Robeco Institutional Asset Management B.V. trimmed its position in shares of Colgate-Palmolive (NYSE:CL) by 2.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,821,487 shares of the company’s stock after selling 63,193 shares during the quarter. Robeco Institutional Asset Management B.V. owned 0.35% of Colgate-Palmolive worth $256,501,000 at the end of the most recent reporting period.

Several other hedge funds have also added to or reduced their stakes in CL. Susquehanna Fundamental Investments LLC bought a new stake in shares of Colgate-Palmolive in the second quarter valued at about $2,125,000. Ascent Group LLC boosted its position in Colgate-Palmolive by 10.1% during the 2nd quarter. Ascent Group LLC now owns 14,022 shares of the company’s stock worth $1,361,000 after acquiring an additional 1,289 shares during the last quarter. Algert Global LLC increased its stake in Colgate-Palmolive by 14.4% in the 2nd quarter. Algert Global LLC now owns 5,131 shares of the company’s stock valued at $498,000 after buying an additional 647 shares during the last quarter. NewEdge Advisors LLC increased its position in shares of Colgate-Palmolive by 11.7% in the second quarter. NewEdge Advisors LLC now owns 51,375 shares of the company’s stock valued at $4,985,000 after acquiring an additional 5,363 shares during the last quarter. Finally, B. Riley Wealth Advisors Inc. increased its holdings in Colgate-Palmolive by 7.3% during the second quarter. B. Riley Wealth Advisors Inc. now owns 17,851 shares of the company’s stock worth $1,732,000 after buying an additional 1,212 shares during the last quarter. Institutional investors and hedge funds own 80.41% of the company’s stock.

Colgate-Palmolive Price Performance

CL stock opened at $89.92 on Wednesday. The company has a market capitalization of $73.47 billion, a P/E ratio of 25.77, a PEG ratio of 3.59 and a beta of 0.44. Colgate-Palmolive has a 52-week low of $82.68 and a 52-week high of $109.30. The company has a fifty day moving average price of $91.67 and a 200-day moving average price of $97.34. The company has a debt-to-equity ratio of 9.46, a quick ratio of 0.68 and a current ratio of 1.04.

Colgate-Palmolive Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st will be given a $0.50 dividend. The ex-dividend date of this dividend is Tuesday, January 21st. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.22%. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 57.31%.

Insider Activity

In other news, CFO Stanley J. Sutula III sold 45,410 shares of the stock in a transaction dated Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the transaction, the chief financial officer now owns 36,726 shares of the company’s stock, valued at $3,456,283.86. This represents a 55.29 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Insiders own 0.34% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have issued reports on the company. Barclays cut their price target on Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating for the company in a report on Friday, January 17th. TD Cowen reduced their target price on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a report on Wednesday, January 8th. UBS Group lowered their price target on shares of Colgate-Palmolive from $112.00 to $104.00 and set a “buy” rating on the stock in a report on Thursday, January 16th. JPMorgan Chase & Co. reduced their price objective on Colgate-Palmolive from $109.00 to $103.00 and set an “overweight” rating for the company in a report on Thursday, January 16th. Finally, Wells Fargo & Company lowered their target price on Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating on the stock in a research note on Tuesday, January 7th. One analyst has rated the stock with a sell rating, ten have issued a hold rating and twelve have given a buy rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Hold” and an average target price of $101.11.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.